Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-600
Closed -$1K 1130
2023
Q2
$1K Hold
600
﹤0.01% 954
2023
Q1
$0 Hold
600
﹤0.01% 987
2022
Q4
$0 Hold
600
﹤0.01% 992
2022
Q3
$1K Hold
600
﹤0.01% 887
2022
Q2
$3K Hold
600
﹤0.01% 742
2022
Q1
$3K Hold
600
﹤0.01% 771
2021
Q4
$4K Hold
600
﹤0.01% 724
2021
Q3
$5K Hold
600
﹤0.01% 676
2021
Q2
$4K Hold
600
﹤0.01% 716
2021
Q1
$4K Hold
600
﹤0.01% 672
2020
Q4
$3K Hold
600
﹤0.01% 672
2020
Q3
$4K Buy
+600
New +$5.34K ﹤0.01% 608

Other funds holding VXRT

Valley National Advisers's VXRT Position: Q3 2023 in Review

Valley National Advisers sold out of Vaxart (VXRT) in Q3 2023, closing a stake of 600 shares — an estimated $1K sold.

Valley National Advisers first reported a position in VXRT in Q3 2020 and held it in 12 quarters. The position peaked at $5K in Q3 2021. 96 funds tracked by Wall St. Rank hold VXRT as of Q3 2023.

  • Valley National Advisers reported no remaining Vaxart position as of Q3 2023 after selling out during the quarter.
  • Valley National Advisers sold 600 Vaxart shares in Q3 2023, an estimated $1K.
  • Valley National Advisers first reported a position in Vaxart in Q3 2020 and held it in 12 quarters.
  • Valley National Advisers's Vaxart position peaked at $5K in Q3 2021.
  • 96 funds tracked by Wall St. Rank held Vaxart as of Q3 2023.

Based on Valley National Advisers's 13F filing for Q3 2023, filed 13 Nov 2023.